August 29, 2016 4:45 AM ET

Biotechnology

Company Overview of Tapestry Pharmaceuticals, Inc.

Key Executives for Tapestry Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Leonard P. Shaykin 20 RelationshipsChairman of the Board and Chief Executive Officer70
Martin M. Batt No RelationshipsChief Operating Officer and Senior Vice President73

Tapestry Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Leonard P. Shaykin 20 RelationshipsTapestry Pharmaceuticals, Inc.70
Paul A. Bunn Jr., M.D. 89 RelationshipsTapestry Pharmaceuticals, Inc.--
George L. Gould J.D., Llm., Ph.D. 26 RelationshipsAspen Aerogels, Inc.78
Valentino J. Stella Ph.D. 28 RelationshipsOrbis Biosciences, Inc.--
Elliot M. Maza J.D., CPA 31 RelationshipsIntellect Neurosciences, Inc.60
View All Board Members

Tapestry Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee J.D., CPAElliot M. Maza31 Relationships3 Executives
Nominating Committee J.D., Llm., Ph.D.George L. Gould26 Relationships1 Executives
Corporate Governance Committee J.D., Llm., Ph.D.George L. Gould26 Relationships1 Executives
Advisory Board Ph.D.Valentino J. Stella28 Relationships14 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$370.0K
370.0K
379.7K
Bonus$350.0K
350.0K
264.9K
Total Short Term Compensation
Not meaningful
Total Value of Options$720.0K
720.0K
33.9M
Compensation as of Fiscal Year 2006
Tapestry Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

ProclaRx Appoints Doug Martin as New Chief Operating Officer
August 27, 2016 7:45 AM ET
OncoCyte Corporation Announces the Resignation of Dr. Michael D. West from Board of Directors
August 19, 2016 8:57 PM ET
Enumeral Biomedical Holdings, Inc. Announces the Resignation of Anhco Nguyen, Ph.D. as Vice President of Research and Development
August 19, 2016 8:30 PM ET
David A. Berry Notifies Eleven Biotherapeutics, Inc. of His Resignation as Member of the Board of Directors and the Compensation Committee
August 19, 2016 8:12 PM ET
Applied Genetic Technologies Corporation Appoints Anne M. VanLent to the Board of Directors
August 18, 2016 8:01 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Tapestry Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.